Dan Lungulescu

749 total citations
6 papers, 68 citations indexed

About

Dan Lungulescu is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dan Lungulescu has authored 6 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Dan Lungulescu's work include Cancer Treatment and Pharmacology (2 papers), Autophagy in Disease and Therapy (1 paper) and Neutropenia and Cancer Infections (1 paper). Dan Lungulescu is often cited by papers focused on Cancer Treatment and Pharmacology (2 papers), Autophagy in Disease and Therapy (1 paper) and Neutropenia and Cancer Infections (1 paper). Dan Lungulescu collaborates with scholars based in Romania, United Kingdom and United States. Dan Lungulescu's co-authors include Andrzej Deptała, I. Bazin, Bruce J. Giantonio, Weijing Sun, Igor Bondarenko, Rubana N. Kalyani, Tudor–Eliade Ciuleanu, Matthew Gribbin, Lucian Miron and Paul Wissel and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Dan Lungulescu

5 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Lungulescu Romania 2 36 29 17 15 13 6 68
Sen Luo China 3 39 1.1× 24 0.8× 14 0.8× 16 1.1× 8 0.6× 5 76
Zigong Shao China 6 64 1.8× 21 0.7× 51 3.0× 21 1.4× 10 0.8× 12 110
Kirsty Lloyd United Kingdom 5 28 0.8× 28 1.0× 14 0.8× 12 0.8× 23 1.8× 9 82
Houjie Liang China 4 25 0.7× 11 0.4× 20 1.2× 7 0.5× 5 0.4× 8 52
Nicholas Pirius United States 5 25 0.7× 24 0.8× 18 1.1× 34 2.3× 4 0.3× 5 88
Yehia I. Abugabal United States 3 15 0.4× 26 0.9× 12 0.7× 46 3.1× 6 0.5× 12 80
Susumu Maruta Japan 3 26 0.7× 21 0.7× 14 0.8× 46 3.1× 14 1.1× 6 79
Qian‐Wen Zheng China 6 46 1.3× 16 0.6× 23 1.4× 3 0.2× 6 0.5× 8 88
Jigjidsuren Chinburen Mongolia 5 27 0.8× 44 1.5× 24 1.4× 51 3.4× 10 0.8× 9 108
Ilenia Cammarata Italy 4 23 0.6× 20 0.7× 6 0.4× 14 0.9× 4 0.3× 7 75

Countries citing papers authored by Dan Lungulescu

Since Specialization
Citations

This map shows the geographic impact of Dan Lungulescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lungulescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lungulescu more than expected).

Fields of papers citing papers by Dan Lungulescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Lungulescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lungulescu. The network helps show where Dan Lungulescu may publish in the future.

Co-authorship network of co-authors of Dan Lungulescu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Lungulescu. A scholar is included among the top collaborators of Dan Lungulescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Lungulescu. Dan Lungulescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Navarro, Alejandro, Egbert F. Smit, Enric Carcereny, et al.. (2023). P2.17-06 Efficacy of Platinum after Lurbinectedin + DOX or Topotecan/CAV in Sensitive Relapsed SCLC Patients in the ATLANTIS Trial. Journal of Thoracic Oncology. 18(11). S380–S381.
2.
Ciuleanu, Tudor–Eliade, I. Bazin, Dan Lungulescu, et al.. (2016). A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma. Annals of Oncology. 27(4). 680–687. 39 indexed citations
3.
Lungulescu, Dan, et al.. (2015). Chemotherapy Related Severe Cardiac Dysfunction - Case Report.. PubMed. 41(4). 395–400. 1 indexed citations
4.
Nicoli, Elena‐Raluca, Florin‐Dan Popescu, Ioana Streață, et al.. (2014). Determination of autophagy gene ATG16L1 polymorphism in human colorectal cancer.. PubMed. 55(1). 57–62. 26 indexed citations
5.
Ciuleanu, Tudor–Eliade, I. Bazin, Dan Lungulescu, et al.. (2014). Final analysis: Randomized, blinded, placebo-controlled phase II trial of sorafenib with and without mapatumumab in patients with advanced hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 32(15_suppl). 4029–4029. 1 indexed citations
6.
Coyle, Vicky M., Dan Lungulescu, Alexander B. Niculescu, et al.. (2013). A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea. British Journal of Cancer. 108(5). 1027–1033. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026